MedPath

Mobile Chat Messaging for Smoking Relapse Prevention

Not Applicable
Active, not recruiting
Conditions
Smoking Cessation
Interventions
Behavioral: Standard smoking cessation treatment
Behavioral: Personalised chat messaging
Behavioral: SMS text messaging
Registration Number
NCT05370352
Lead Sponsor
The University of Hong Kong
Brief Summary

Most smokers return to smoking (relapse) after making a quit attempt, but evidence of effective intervention to prevent relapse is scarce. Taking advantage of recent advances in mobile technologies, this study aims to evaluate the effectiveness of a mobile chat messaging-based relapse prevention intervention in promoting successful quitting in people who recently quit smoking (recent abstainers) using a randomised controlled trial design.

Detailed Description

Most smokers who made quit attempts and achieved short-term abstinence return to smoking (relapse) over time, even when aided by effective smoking cessation treatment. Since relapse mostly occurred in the first 4 weeks of abstinence, relapse prevention in the early phase of abstinence could potentially boost long-term abstinence. Several behavioural interventions for smoking relapse prevention have been proposed and tested in RCTs. Yet, a 2019 Cochrane review did not find traditional approaches, including self-help materials, telephone counselling and group therapy, effective in increasing long-term abstinence at 6 months or longer.

The widespread use of mobile devices has provided a highly accessible and scalable means for novel behavioural interventions for smoking cessation. A formative qualitative study in current smokers conducted by the investigators showed that mobile chat messaging is a feasible and acceptable platform for delivering smoking cessation support. A subsequent cluster randomised controlled trial on 1148 smokers found that mobile chat messaging combined with brief intervention was effective in increasing biochemically validated abstinence at 6 months. Nonetheless, whether mobile chat messaging could prevent relapse in recent abstainers has remained untested.

The investigators did a pilot trial to confirm the feasibility and acceptability of mobile chat messaging for relapse prevention in recent abstainers. This study aims to evaluate the effectiveness of mobile chat messaging relapse prevention intervention in promoting abstinence in recent abstainers.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
590
Inclusion Criteria
  • Hong Kong residents aged 18 years or above
  • Own a smartphone with WhatsApp installed
  • Enrolled in a smoking cessation program under Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation
  • Smoked daily before the present quit attempt
  • Abstained from smoking for 3 to 30 days
Exclusion Criteria
  • Diagnosed with a mental disease or on regular psychotropic drugs
  • Participating in other ongoing smoking cessation studies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mobile chat messagingStandard smoking cessation treatmentStandard smoking cessation treatment + Personalised chat messaging
Mobile chat messagingPersonalised chat messagingStandard smoking cessation treatment + Personalised chat messaging
SMS messagingSMS text messagingStandard smoking cessation treatment + Regular SMS text messaging generic information about the harms of smoking and the benefits of quitting
SMS messagingStandard smoking cessation treatmentStandard smoking cessation treatment + Regular SMS text messaging generic information about the harms of smoking and the benefits of quitting
Primary Outcome Measures
NameTimeMethod
Biochemically validated tobacco abstinence6 months after randomisation

Verified by an exhaled carbon monoxide level of lower than 5 parts per million or a negative salivary cotinine test

Secondary Outcome Measures
NameTimeMethod
Biochemically validated tobacco abstinence12 months after randomisation

Verified by an exhaled carbon monoxide level of lower than 5 parts per million or a negative salivary cotinine test

Self-reported 6-month prolonged tobacco abstinence6 months after randomisation

Not more than five lapses permitted for 6 months after baseline

Self-reported 7-day point prevalent tobacco abstinence12 months after randomisation

Being completely smoke-free in the past 7 days

Self-reported relapse rate12 months after randomisation

Defined as use of tobacco products for 7 consecutive days or longer

Self-reported 12-month prolonged tobacco abstinence12 months after randomisation

Not more than five lapses permitted for 12 months after baseline

Trial Locations

Locations (2)

Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation

🇭🇰

Hong Kong, Hong Kong

United Christian Nethersole Community Health Service Smoking Cessation Programme

🇭🇰

Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath